WO2007115697A1 - Verfahren zur herstellung von polyurethan-schäumen - Google Patents

Verfahren zur herstellung von polyurethan-schäumen Download PDF

Info

Publication number
WO2007115697A1
WO2007115697A1 PCT/EP2007/002801 EP2007002801W WO2007115697A1 WO 2007115697 A1 WO2007115697 A1 WO 2007115697A1 EP 2007002801 W EP2007002801 W EP 2007002801W WO 2007115697 A1 WO2007115697 A1 WO 2007115697A1
Authority
WO
WIPO (PCT)
Prior art keywords
anionic
polyurethane
acid
wound dressings
dispersions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2007/002801
Other languages
German (de)
English (en)
French (fr)
Inventor
Michael Mager
Thorsten Rische
Sebastian Dörr
Thomas Feller
Michael Heckes
Melita Dietze
Burkhard Fugmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Covestro Deutschland AG
Bayer Innovation GmbH
Original Assignee
Bayer Innovation GmbH
Bayer MaterialScience AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Innovation GmbH, Bayer MaterialScience AG filed Critical Bayer Innovation GmbH
Priority to EP07723745.1A priority Critical patent/EP2010235B1/de
Priority to MX2008012955A priority patent/MX2008012955A/es
Priority to AU2007236253A priority patent/AU2007236253A1/en
Priority to CN2007800212484A priority patent/CN101466413B/zh
Priority to BRPI0709826-0A priority patent/BRPI0709826A2/pt
Priority to JP2009504604A priority patent/JP2009534478A/ja
Priority to CA002648362A priority patent/CA2648362A1/en
Publication of WO2007115697A1 publication Critical patent/WO2007115697A1/de
Priority to IL194551A priority patent/IL194551A0/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40High-molecular-weight compounds
    • C08G18/48Polyethers
    • C08G18/4854Polyethers containing oxyalkylene groups having four carbon atoms in the alkylene group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/425Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08Processes
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08Processes
    • C08G18/0804Manufacture of polymers containing ionic or ionogenic groups
    • C08G18/0819Manufacture of polymers containing ionic or ionogenic groups containing anionic or anionogenic groups
    • C08G18/0828Manufacture of polymers containing ionic or ionogenic groups containing anionic or anionogenic groups containing sulfonate groups or groups forming them
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08Processes
    • C08G18/0838Manufacture of polymers in the presence of non-reactive compounds
    • C08G18/0842Manufacture of polymers in the presence of non-reactive compounds in the presence of liquid diluents
    • C08G18/0861Manufacture of polymers in the presence of non-reactive compounds in the presence of liquid diluents in the presence of a dispersing phase for the polymers or a phase dispersed in the polymers
    • C08G18/0866Manufacture of polymers in the presence of non-reactive compounds in the presence of liquid diluents in the presence of a dispersing phase for the polymers or a phase dispersed in the polymers the dispersing or dispersed phase being an aqueous medium
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08Processes
    • C08G18/10Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step
    • C08G18/12Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step using two or more compounds having active hydrogen in the first polymerisation step
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/2805Compounds having only one group containing active hydrogen
    • C08G18/2815Monohydroxy compounds
    • C08G18/283Compounds containing ether groups, e.g. oxyalkylated monohydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40High-molecular-weight compounds
    • C08G18/4009Two or more macromolecular compounds not provided for in one single group of groups C08G18/42 - C08G18/64
    • C08G18/4018Mixtures of compounds of group C08G18/42 with compounds of group C08G18/48
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40High-molecular-weight compounds
    • C08G18/42Polycondensates having carboxylic or carbonic ester groups in the main chain
    • C08G18/44Polycarbonates
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40High-molecular-weight compounds
    • C08G18/48Polyethers
    • C08G18/4804Two or more polyethers of different physical or chemical nature
    • C08G18/4808Mixtures of two or more polyetherdiols
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/70Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
    • C08G18/72Polyisocyanates or polyisothiocyanates
    • C08G18/721Two or more polyisocyanates not provided for in one single group C08G18/73 - C08G18/80
    • C08G18/722Combination of two or more aliphatic and/or cycloaliphatic polyisocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602Type of release, e.g. controlled, sustained, slow

Definitions

  • the invention relates to a process for the production of polyurethane foams, by foaming and drying of special polyurethane dispersions.
  • hydrophilic polyurethane foams are generally used for this purpose. These are obtained by reacting mixtures of diisocyanates and polyols or NCO-functional polyurethane prepolymers with water in the presence of certain catalysts and (foam) additives. As a rule, aromatic diisocyanates are used here, since they are best foamed. Numerous embodiments of these methods are known, for example described in US 3,978,266, US 3,975,567 and EP-A 0 059 048. However, the aforementioned methods have the disadvantage that reactive mixtures must be used, containing diisocyanates or corresponding prepolymers whose handling is technically complicated , because eg appropriate protective measures are required.
  • foams from polyurethane dispersions by adding air in the presence of suitable (foam) additives by vigorous stirring. After drying and curing, so-called mechanical polyurethane foams are obtained.
  • foams are described in connection with wound dressings in EP-A 0 235 949 and EP-A 0 246 723, either adding a self-adherent polymer to the foam or applying the foam to a film of a self-adherent polymer. The use of the foams as such, ie without self-adherent polymers is not described.
  • EP 0 235 949 and EP 0 246 723 are absolutely mandatory for the use of polyaziridines as crosslinkers, which according to the current state of knowledge are no longer acceptable because of their toxicity.
  • high baking temperatures must be applied are given 100 0 C to 170 0 C.
  • US 4,655,210 the use of the aforesaid mechanical foams for wound dressings, which have a specific construction of a carrier, foam and skin contact layer.
  • Dispersions are anionically hydrophilicized by incorporation of certain carboxylic acids such as dimethylolcarboxylic acids and neutralization of the carboxylic acids with tertiary amines, for example triethylamine.
  • carboxylic acids such as dimethylolcarboxylic acids
  • tertiary amines for example triethylamine.
  • the ammonium carboxylates thus formed are decomposable, especially at higher temperatures, thereby releasing the amines again become. This is a great disadvantage in the processing of such products and especially in skin contact.
  • the dimethy lolcarbon yarnren were also used dissolved, for example, in dimethylformamide or N-methylpyrrolidone, whereby the finished products have a high total content of health-critical volatile organic compounds (VOC), in the case of used Witcobond TM 290 H 10.8 g / liter (without water).
  • VOC health-critical volatile organic compounds
  • EP-A 0 760 743 moreover describes such mechanical foams based on latex dispersions, which however do not consist of polyurethanes and have inferior mechanical properties.
  • Object of the present invention was therefore the provision of new wound dressings based on polyurethanes, which are accessible in the simplest possible way and without the use of harmful building components or additives. Another prerequisite is that these wound dressings have good mechanical properties, a high absorption capacity of physiological saline solution and a high water vapor permeability.
  • the present invention therefore relates to a process for the production of wound dressings, in which compositions containing anionically hydrophilicized, aqueous polyurethane dispersions (I) are foamed and dried physically without chemical crosslinking.
  • crosslinking means the formation of covalent bonds.
  • Wound coatings of polyurethane foams in the context of the invention are porous materials, preferably with at least partially existing open cell, which essentially consist of polyurethanes and protect wounds in terms of sterile coverage from germs or environmental influences, rapid and high absorption of physiological saline solution or Having wound fluid, provide by suitable moisture permeability for a suitable wound climate and have sufficient mechanical strength.
  • These dispersions are preferably hydrophilized anionically by means of sulfonate groups. Especially preferred for anionic hydrophilization are exclusively sulfonate groups.
  • the specific polyurethane dispersions (I) preferably have a low degree of hydrophilic anionic groups, preferably from 0.1 to 15 milliequivalents per 100 g
  • the number-average particle size of the specific polyurethane dispersions is preferably less than 750 nm, more preferably less than 500 nm, determined by means of laser correlation spectroscopy.
  • the polyurethane dispersions (I) preferably have solids contents of from 30 to 70% by weight, particularly preferably from 50 to 70% by weight, very particularly preferably from 55 to 65% by weight and in particular from 60 to 65% by weight on the polyurethane contained therein.
  • polyurethane dispersions preferably have less than 0.5% by weight, more preferably less than 0.2% by weight, based on the total dispersions, of unbound organic amines.
  • Such preferably used polyurethane dispersions (I) are obtainable in which
  • polymeric polyols having number average molecular weights of 400 to 8000 g / mol, preferably 400 to 6000 g / mol and particularly preferably of
  • A3) optionally hydroxy-functional compounds having molecular weights of 62 to 399 g / mol and A4) optionally isocyanate-reactive, anionic or potentially anionic and / or optionally nonionic hydrophilicizing agents,
  • Step B) are dispersed in water.
  • the prepolymer can be completely or partially converted into the anionic form before, during or after the dispersion by admixing a base.
  • hydrophilizing agents which have at least one NCO-reactive group, such as amino, hydroxy or thiol groups, and furthermore -COO " or -SO 3 " or -PO 3 2 " as anionic or their fully or partially protonated acid forms as potentially anionic groups.
  • Suitable polyisocyanates of component A1) are the aliphatic or cycloaliphatic polyisocyanates of an NCO functionality greater than or equal to 2 known to the person skilled in the art.
  • polystyrene resin examples include 1,4-butylene diisocyanate, 1,6-hexamethylene diisocyanate (HDI), isophorone diisocyanate (IPDI), 2,2,4- and / or 2,4,4-trimethylhexamethylene diisocyanate, and the isomeric bisisocyanate.
  • HDI 1,6-hexamethylene diisocyanate
  • IPDI isophorone diisocyanate
  • 2,2,4- and / or 2,4,4-trimethylhexamethylene diisocyanate examples include 1,4-butylene diisocyanate, 1,6-hexamethylene diisocyanate (HDI), isophorone diisocyanate (IPDI), 2,2,4- and / or 2,4,4-trimethylhexamethylene diisocyanate, and the isomeric bisisocyanate.
  • polyisocyanates which have a functionality of> 2, with uretdione, isocyanurate, urethane, allophanate, biuret, iminooxadiazinedione or oxadiazine-trione structure, and also mixtures of these proportions.
  • Hexamethylene diisocyanate, isophorone diisocyanate or the isomeric bis (4,4'-isocyanatocyclohexyl) methanes and mixtures of the abovementioned diisocyanates are particularly preferably used in Al).
  • polymeric polyols having a number average molecular weight M n of 400 to 8000 g / mol, preferably from 400 to 6000 g / mol and particularly preferably from 600 to 3000 g / mol. These preferably have an OH functionality of from 1.5 to 6, particularly preferably from 1.8 to 3, very particularly preferably from 1.9 to 2.1.
  • Such polymeric polyols are the polyester polyols known per se in polyurethane coating technology, polyacrylate polyols, polyurethane polyols, polycarbonate polyols, polyether polyols, polyester polyacrylate polyols, polyurethane polyacrylate polyols, polyurethane polyester polyols, polyurethane polyether polyols, polyurethane polycarbonate polyols and polyester polycarbonate polyols. These can be used in A2) individually or in any mixtures with each other.
  • polyester polyols are the known polycondensates of di- and optionally tri- and tetraols and di- and optionally tri- and tetracarboxylic acids or hydroxycarboxylic acids or lactones.
  • free polycarboxylic acids it is also possible to use the corresponding polycarboxylic acid anhydrides or corresponding polycarboxylic acid esters of lower alcohols for the preparation of the polyesters.
  • diols examples include ethylene glycol, butylene glycol, diethylene glycol, triethylene glycol, polyalkylene glycols such as polyethylene glycol, furthermore 1,2-propanediol, 1,3-propanediol, butanediol (1,3), butanediol (1,4), hexanediol ( l, 6) and isomers, neopentyl glycol or
  • Hydroxypivalic acid neopentyl glycol esters, with hexanediol (1,6) and isomers, butanediol (1,4), neopentyl glycol and neopentyl glycol hydroxypivalate being preferred.
  • polyols such as trimethylolpropane, glycerol, erythritol, pentaerythritol, trimethylolbenzene or trishydroxyethyl isocyanurate.
  • phthalic acid isophthalic acid, terephthalic acid, tetrahydrophthalic acid, hexahydrophthalic acid, cyclohexanedicarboxylic acid, adipic acid, azelaic acid, sebacic acid, glutaric acid, tetrachlorophthalic acid, maleic acid, fumaric acid, itaconic acid, malonic acid, suberic acid, 2-methyl succinic acid, 3,3-diethylglutaric acid and / or 2 , 2-dimethyl- ethylsuccinic acid are used.
  • the acid source used may also be the corresponding anhydrides.
  • monocarboxylic acids such as benzoic acid and hexanecarboxylic acid may additionally be used.
  • Preferred acids are aliphatic or aromatic acids of the abovementioned type.
  • adipic acid isophthalic acid and phthalic acid.
  • Hydroxycarboxylic acids which may be co-used as reactants in the preparation of a hydroxyl-terminated polyester polyol include hydroxycaproic acid, hydroxybutyric acid, hydroxydecanoic acid, hydroxystearic acid and the like.
  • Suitable lactones are caprolactone, butyrolactone and homologs. Preference is given to caprolactone.
  • hydroxyl-containing polycarbonates preferably polycarbonatediols, having number-average molecular weights M n of from 400 to 8000 g / mol, preferably from 600 to 3000 g / mol.
  • carbonic acid derivatives such as diphenyl carbonate, dimethyl carbonate or phosgene
  • diols examples include ethylene glycol, 1,2- and 1,3-propanediol, 1,3- and 1,4-butanediol, 1,6-hexanediol, 1,8-octanediol, neopentyl glycol, 1,4-bishydroxymethylcyclohexane, 2-Methyl-l, 3-propanediol, 2,2,4-Trimethylpentandiol-l, 3, dipropylene glycol, polypropylene glycols, dibutylene glycol, polybutylene glycols, bisphenol A and lactone-modified diols of the aforementioned type in question.
  • the diol component contains 40 to 100 wt .-% of hexanediol, preferably 1,6-hexanediol and / or hexanediol derivatives.
  • hexanediol derivatives are based on hexanediol and have ester or ether groups in addition to terminal OH groups.
  • Such derivatives are obtainable by reaction of hexanediol with excess caprolactone or by etherification of hexanediol with itself to give di- or triethylene glycol.
  • Hydroxyl-containing polycarbonates are preferably built linear.
  • polyether polyols can be used.
  • polytetra methylene glycol polyethers known per se in polyurethane chemistry such as are obtainable by polymerization of tetrahydrofuran by means of cationic ring opening, are suitable.
  • polyether polyols are the per se known addition products of styrene oxide, ethylene oxide, propylene oxide, butylene oxide and / or epichlorohydrin to di- or polyfunctional starter molecules.
  • Polyether polyols, based on the at least proportional addition of ethylene oxide to di- or polyfunctional starter molecules, can also be used as component A4) (nonionic hydrophilicizing agents).
  • starter molecules it is possible to use all known compounds according to the prior art, such as, for example, water, butyldiglycol, glycerol, diethylene glycol, trimethylolpropane, propylene glycol, sorbitol, ethylenediamine, triethanolamine, 1,4-butanediol.
  • polyols of the stated molecular weight range having up to 20 carbon atoms such as ethylene glycol, diethylene glycol, triethylene glycol, 1,2-propanediol, 1,3-propanediol, 1,4-butanediol, 1,3-butylene glycol, cyclohexanediol, 1,4 cyclohexanedimethanol,
  • ester diols of the stated molecular weight range, such as ⁇ -hydroxybutyl- ⁇ -hydroxycaproic acid ester, ⁇ -hydroxyhexyl- ⁇ -hydroxybutyric acid ester, adipic acid ( ⁇ -hydroxyethyl) ester or terephthalic acid bis ( ⁇ -hydroxyethyl) ester.
  • monofunctional isocyanate-reactive hydroxyl group-containing compounds can also be used in A3).
  • monofunctional compounds are ethanol, n-butanol, ethylene glycol monobutyl ether, diethylene glycol monomethyl ether,
  • Suitable anionic hydrophilic compounds of component A4) are salts of
  • Mono- and Dihydroxysulfonklaren Mono- and Dihydroxysulfonklaren.
  • anionic hydrophilicizing agents are the adduct of sodium bisulfite with butene-2-diol-1,4, as described in DE-A 2 446 440, pages 5-9, formula I-HI.
  • Suitable nonionically hydrophilicizing compounds of component A4) are, for example, polyoxyalkylene ethers which contain at least one hydroxyl, amino or thiol group.
  • Examples are the monohydroxy-functional, on average 5 to 70, preferably 7 to 55 ethylene oxide units per molecule having Polyalkylenoxidpolyetheralkohole as they are accessible in a conventional manner by alkoxylation of suitable starter molecules (eg in Ulimann's Encyclopaedia of Industrial Chemistry, 4th Edition, Volume 19 , Verlag Chemie, Weinheim pp. 31-38). These are either pure polyethylene oxide ethers or mixed polyalkylene oxide ethers, wherein they contain at least 30 mol%, preferably at least 40 mol%, of ethylene oxide units based on all the alkylene oxide units present.
  • Particularly preferred nonionic compounds are monofunctional mixed polyalkylene oxide polyethers which have 40 to 100 mol% of ethylene oxide and 0 to 60 mol% of propylene oxide units.
  • Suitable starter molecules for such nonionic hydrophilicizing agents are saturated monoalcohols, such as methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, sec-
  • Butanol the isomeric pentanols, hexanols, octanols and nonanols, n-decanol, n-dodecanol, n-tetradecanol, n-hexadecanol, n-octadecanol, cyclohexanol, the isomeric methylcyclohexanols or hydroxymethylcyclohexane, 3-ethyl-3- hydroxymethyloxetane or tetrahydrofurfuryl alcohol, diethylene glycol monoalkyl ethers, such as diethylene glycol monobutyl ether, unsaturated alcohols such as allyl alcohol, 1,1-dimethylallyl alcohol or
  • Oleic alcohol aromatic alcohols such as phenol, the isomeric cresols or methoxyphenols, araliphatic alcohols such as benzyl alcohol, anisalcohol or cinnamyl alcohol, secondary monoamines such as dimethylamine, diethylamine, dipropylamine, diisopropylamine, dibutylamine, bis (2-ethylhexyl) amine, N-methyl and N-ethylcyclohexylamine or dicyclohexylamine and heterocyclic secondary amines such as morpholine, pyrrolidine, piperidine or 1H-pyrazole.
  • Preferred starter molecules are saturated monoalcohols of the abovementioned type. Particular preference is given to using diethylene glycol monobutyl ether or n-butanol as starter molecules.
  • Alkylene oxides which are suitable for the alkoxylation reaction are, in particular, ethylene oxide and propylene oxide, which can be used in any desired order or even as a mixture in the alkoxylation reaction.
  • organic di- or polyamines such as, for example, 1,2-ethylenediamine, 1,2- and 1,3-diaminopropane, 1,4-diaminobutane, 1,6-diaminohexane, isophorone diamine, isomer mixture of 2 , 2,4- and 2,4,4-trimethylhexamethylenediamine, 2-methyl- pentamethylenediamine, diethylenetriamine, 4,4-diaminodicyclohexylmethane and / or dimethyl ethylenediamine.
  • 1,2-ethylenediamine 1,2- and 1,3-diaminopropane
  • 1,4-diaminobutane 1,6-diaminohexane
  • isophorone diamine isomer mixture of 2 , 2,4- and 2,4,4-trimethylhexamethylenediamine, 2-methyl- pentamethylenediamine, diethylenetriamine, 4,4-diaminodicyclohexylmethane
  • component Bl compounds which, in addition to a primary amino group, also have secondary amino groups or, in addition to an amino group (primary or secondary), also OH groups, can be used.
  • primary / secondary amines such as diethanolamine, 3-amino-1-methylaminopropane, 3-amino-1-one
  • ethylaminopropane 3-amino-1-cyclohexylaminopropane, 3-amino-1-methylaminobutane, alkanolamines such as N-aminoethylethanolamine, ethanolamine, 3-aminopropanol, neopentanolamine.
  • component Bl it is also possible to use monofunctional isocyanate-reactive amine compounds, for example methylamine, ethylamine, propylamine, butylamine, octylamine, laurylamine, stearylamine, isononyloxypropylamine, dimethylamine, diethylamine, dipropylamine, dibutylamine, N-methylaminopropylamine, diethyl (methyl) - aminopropylamine, Mo ⁇ holin, piperidine, or suitable substituted derivatives thereof, amide amines from diprimary amines and monocarboxylic acids, monoketim of diprimary amines, primary / tertiary amines, such as N, N-dimethylaminopropylamine.
  • monofunctional isocyanate-reactive amine compounds for example methylamine, ethylamine, propylamine, butylamine, octylamine, laurylamine, stearyl
  • Suitable anionically hydrophilicizing compounds of component B2) are alkali metal salts of mono- and diaminosulfonic acids.
  • anionic hydrophilizing agents are salts of 2- (2-aminoethylamino) ethanesulfonic acid, ethylenediamine propyl- or -butylsulfonic acid, 1,2- or 1,3-propylenediamine-.beta.-ethylsulfonic acid or
  • the salt of cyclohexylaminopropanesulfonic acid (CAPS) from WO-A 01/88006 can be used as an anionic hydrophilicizing agent.
  • Particularly preferred anionic hydrophilicizing agents B2) are those which contain sulfonate groups as ionic groups and two amino groups, such as the salts of 2- (2-aminoethylamino) ethylsulfonic acid and 1,3-propylenediamine- ⁇ -ethylsulfonic acid.
  • hydrophilization it is also possible to use mixtures of anionic and nonionic hydrophilicizing agents.
  • the components A1) to A4) and B1) to B2) are used in the following amounts, the individual amounts always adding up to 100% by weight:
  • the components A1) to A4) and B1) to B2) are used in the following amounts, the individual amounts always adding up to 100% by weight:
  • the components A1) to A4) and B1) to B2) are used in the following amounts, the individual amounts always adding up to 100% by weight:
  • the preparation of the special polyurethane dispersions can be carried out in one or more stages in homogeneous or in multistage reaction, in some cases in disperse phase. After complete or partial polyaddition from Al) to A4) a dispersing, emulsifying or dissolving step takes place. This is followed, if appropriate, by a further polyaddition or modification in disperse phase.
  • Example prepolymer mixing method, acetone method or Schmelzdispergiervon can be used. It is preferred to proceed according to the acetone method.
  • the constituents A2) to A4) and the polyisocyanate component Al) are initially introduced in whole or in part to prepare an isocyanate-functional polyurethane prepolymer and optionally diluted with a water-miscible but isocyanate-inert solvent and cooled to temperatures in the Range of 50 to 120 0 C heated.
  • a water-miscible but isocyanate-inert solvent a water-miscible but isocyanate-inert solvent
  • Suitable solvents are the customary aliphatic, ketofunctional solvents, such as acetone, 2-butanone, which can also be added later, not only at the beginning of the preparation but, if appropriate, in parts. Preference is given to acetone and 2-butanone, particular preference to acetone.
  • the molar ratio of isocyanate groups to isocyanate-reactive groups is 1.05 to 3.5, preferably 1.1 to 3.0, particularly preferably 1.1 to 2, 5th
  • Suitable components for chain extension are organic di- or polyamines B1) such as, for example, ethylenediamine, 1,2- and 1,3-diaminopropane, 1,4-diaminobutane, 1,6-diaminohexane, isophoronediamine, mixture of 2,2,4- and isomers 2,4,4-trimethylhexamethylenediamine, 2-methylpentamethylenediamine, diethylenetriamine, diaminodicyclohexylmethane and / or dimethylethylenediamine.
  • organic di- or polyamines B1 such as, for example, ethylenediamine, 1,2- and 1,3-diaminopropane, 1,4-diaminobutane, 1,6-diaminohexane, isophoronediamine, mixture of 2,2,4- and isomers 2,4,4-trimethylhexamethylenediamine, 2-methylpentamethylenediamine, diethylenetriamine, diaminodicy
  • compounds B1) which, in addition to a primary amino group, also have secondary amino groups or, in addition to an amino group (primary or secondary), also OH groups.
  • primary / secondary amines such as diethanolamine, 3-amino-1-methylaminopropane, 3-amino-1-ethylaminopropane, 3-amino-1-cyclohexylaminopropane, 3-amino-1-methylaminobutane, alkanolamines, such as N-
  • Aminoethylethanolamine, ethanolamine, 3-aminopropanol, neopentanolamine be used for chain extension or termination.
  • amines Bl are usually used with an isocyanate-reactive group, such as methylamine, ethylamine, propylamine, butylamine, octylamine, laurylamine, stearylamine, isononyloxypropylamine, dimethylamine, diethylamine, dipropylamine,
  • an isocyanate-reactive group such as methylamine, ethylamine, propylamine, butylamine, octylamine, laurylamine, stearylamine, isononyloxypropylamine, dimethylamine, diethylamine, dipropylamine,
  • the chain extension of the prepolymers is preferably carried out before the dispersion.
  • the chain extension ie the equivalent ratio of NCO-reactive groups of the compounds used for chain extension and chain termination to free NCO groups of the prepolymer, is between 40 and 150%, preferably between 50 and
  • the aminic components B1) and B2) can, if appropriate, be used in water-diluted or solvent-diluted form in the process according to the invention individually or in mixtures, it being possible in principle for any order of addition to be possible.
  • the diluent content in the chain-extending component used in B) is preferably 70 to 95% by weight.
  • the dispersion preferably takes place after the chain extension.
  • the dissolved and chain-extended polyurethane polymer is optionally added either under strong shear, such as strong stirring, either in the dispersing water or, conversely, the dispersing water is stirred into the chain-extended polyurethane polymer solutions.
  • the water is added to the dissolved chain-extended polyurethane polymer.
  • the solvent still present in the dispersions after the dispersion step is then usually removed by distillation. A removal already during the dispersion is also possible.
  • the residual content of organic solvents in the dispersions essential to the invention is typically less than 1% by weight, preferably less than 0.5% by weight, based on the total dispersion.
  • the pH of the dispersions essential to the invention is typically less than 8.0, preferably less than 7.5, and more preferably between 5.5 and 7.5.
  • compositions to be foamed may also contain auxiliaries and additives (II).
  • auxiliaries and additives are foam auxiliaries, such as foaming agents and stabilizers, thickeners or thixotropic agents, antioxidants, light stabilizers, emulsifiers, plasticizers, pigments, fillers and leveling agents.
  • auxiliary agents and additives (II) are foam auxiliaries, such as foaming agents and
  • Stabilizers included. Suitable compounds are commercially available compounds such as fatty acid amides, hydrocarbon sulfonates, sulfates or fatty acid salts, the lipophilic radical preferably containing from 12 to 24 carbon atoms, and alkylpolyglycosides which are known to the person skilled in the art by reaction of relatively long-chain monoalcohols (4 to 22 C atoms in the Alkyl residue) with mono-, di- or polysaccharides (see, eg, Kirk-Othmer, Encyclopedia of Chemical Technology, John Wiley & Sons, Vol. 24, p. 29).
  • Preferred foam auxiliaries are sulfosuccinamides, alkanesulfonates or sulfates having 12 to 22 carbon atoms in the hydrocarbon radical, alkylbenzenesulfonates or sulfates having 14 to 24 carbon atoms in the hydrocarbon radical or fatty acid amides or fatty acid salts having 12 to 24 carbon atoms.
  • Such fatty acid amides are preferably those based on mono- or di- (C2-3-alkanol) amines.
  • the fatty acid salts may be, for example, alkali metal salts, amine salts or unsubstituted ammonium salts.
  • Such fatty acid derivatives are typically based on fatty acids such as lauric acid, myristic acid, palmitic acid, oleic acid, stearic acid, ricinoleic acid, behenic acid or arachidic acid,
  • Particularly preferred foam auxiliaries are mixtures of sulfosuccinamides and ammonium stearates, these preferably being from 20 to 60% by weight, particularly preferably from 30 to 50% by weight, of ammonium stearates and preferably from 80 to 40% by weight, particularly preferably from 70 to 50% by weight contained in sulfosuccinamides.
  • thickeners may be used as thickeners, such as dextrin, starch or cellulose derivatives, e.g. Cellulose ethers or hydroxyethylcellulose, organic fully synthetic thickeners based on polyacrylic acids, polyvinylpyrrolidones, poly (meth) - acrylic compounds or polyurethanes (associative thickeners) and inorganic Verdiker, such as Betonite or silica.
  • the foaming in the process of the invention is done by mechanical stirring of the composition at high speeds by shaking or by relaxing a propellant gas.
  • the mechanical foaming can be carried out with any mechanical stirring, mixing and dispersing techniques. As a rule, this air is entered, but also nitrogen and other gases can be used for this purpose.
  • the foam thus obtained is applied to a substrate during foaming or immediately thereafter or placed in a mold and dried.
  • the order can be made, for example, by casting or knife coating, but other techniques known per se are possible.
  • a multi-layer application with intermediate drying steps is basically also possible.
  • Temperatures of 200 0 C preferably 150 0 C, more preferably 130 0 C not exceeded Otherwise, unwanted yellowing of the foams may occur. Also possible is a two- or multi-stage drying.
  • the drying is usually carried out using known heating and drying equipment, such as (convection) drying cabinets, hot air or IR lamps.
  • the application and the drying can each be carried out batchwise or continuously, but preference is given to a completely continuous process.
  • Suitable substrates are papers or films which allow a simple detachment of the wound dressing before it is used to cover an injured area.
  • the substrate may be human or animal tissue such as skin, so that a direct closure of an injured site by an in situ prepared wound dressing is possible.
  • a further subject matter is the wound dressings obtainable by the process according to the invention.
  • the wound dressings Before being dried, the wound dressings typically have foam densities of 50 to 800 g / liter, preferably 100 to 500 g / liter, particularly preferably 100 to 250 g / liter (mass of all starting materials [in g] based on the foam volume of one liter).
  • the wound dressings After being dried, the wound dressings have a microporous, open-pore structure with cells which communicate with one another.
  • the density of the dried foams is typically below 0.4 g / cm 3 , it is preferably less than 0.35 g / cm 3 , particularly preferably 0.01 to 0.3 g / cm 3 and is very particularly preferred 0.15 to 0.3 g / cm 3 .
  • the absorption capacity with respect to physiological saline solution in the case of polyurethane foams is typically 100 to 1500%, preferably 300 to 1500%, particularly preferably 300 to 800% (mass of the liquid absorbed, based on the mass of the dry foam, determination according to DIN EN 13726-1, Part 3.2).
  • the permeability to water vapor is typically 2000 to 8000 g / 24 h * m 2 , preferably 3000 to 8000 g / 24 h * m 2 , particularly preferably 3000 to 5000 g / 24 h * m 2 (determination according to US Pat
  • the polyurethane foams have good mechanical strength and high elasticity.
  • the values for the maximum stress are greater than 0.2 N / mm 2 and the maximum elongation is greater than 250%.
  • the maximum stress is greater than 0.4 N / mm 2 and the elongation greater than 350% (determined according to DIN 53504).
  • the wound dressings after drying typically have a thickness of 0.1 mm to 50 mm, preferably 0.5 mm to 20 mm, more preferably 1 to 10 mm, most preferably 1 to 5 mm.
  • wound dressings can moreover be bonded, laminated or coated with other materials, for example based on hydrogels, (semi-) permeable films,
  • Coatings Hydrocolloids or other foams.
  • a step for sterilization can take place in the process according to the invention.
  • the processes known to those skilled in the art are used, in which sterilization by thermal treatment, chemical substances such as ethylene oxide or irradiation, for example by gamma irradiation.
  • the polyurethane dispersion (I) is mixed with foam auxiliaries of the abovementioned type, then mechanically foamed by introducing a gas such as air.
  • This foam is applied to a substrate and physically dried. Due to higher productivity, the drying is typically carried out at elevated temperatures of 30 to 200 0 C, preferably 50 to 15O 0 C, more preferably 60 to 130 0 C. Also preferred is at least a two-stage drying starting at temperatures of 40 to 80 0 C and with subsequent drying at elevated temperatures of 80 to 140 0 C.
  • the drying is usually carried out using known heating and drying equipment, such as (convection) drying cabinets.
  • the application and the drying can each be carried out batchwise or continuously, but it is preferred to use entirely continuous processes.
  • a sterilization step can be achieved during or after the process by irradiation or addition of suitable substances.
  • the polyurethane dispersion (I) is formulated with a foam aid and a blowing agent, so that at the same time a foaming is used during spraying.
  • the foam formed is then dried, with temperatures of 20 to 40 0 C already sufficient.
  • additional heat sources such as hair dryer or IR red light lamp but also a forced heat drying up to 80 0 C is possible.
  • blowing agents used are known per se from polyurethane chemistry.
  • n-butane, i-butane and propane and mixtures of these hydrocarbons are suitable, but also suitable is dimethyl ether, for example.
  • dimethyl ether for example.
  • a mixture of n-butane, i-butane and propane is used, whereby the desired, fine-celled foams are obtained.
  • the propellant or the propellant mixture is typically used in an amount of 1 to 50 wt .-%, preferably 5 to 40 wt .-% and particularly preferably 5 to 20 wt .-%, wherein the sum of polyurethane dispersion used (I ), Blowing agent (mixture) and optionally used auxiliaries and additives (H) 100 wt .-% results.
  • the provision of the spray plaster is preferably carried out in spray cans. In addition to spraying, casting of the composition is also possible.
  • the solids contents were determined according to DIN-EN ISO 3251.
  • NCO contents were determined volumetrically in accordance with DIN EN ISO 11909, unless expressly stated otherwise.
  • control on free NCO groups was determined by IR spectroscopy (band at 2260 cm “ ') is carried out.
  • the indicated viscosities were determined by means of rotational viscometry according to DIN 53019 at 23 ° C. using a rotational viscometer from Anton Paar Germany GmbH, Ostfildern, DE.
  • Diaminosulphonate NH 2 -CH 2 CH 2 -NH-CH 2 CH 2 -SO 3 Na (45% in water)
  • Desmophen ® 2020 / C2200 polycarbonate polyol, OH number 56 mg KOH / g, number average molecular weight 2000 g / mol (Bayer MaterialScience AG, Leverkusen, DE)
  • PolyTHF ® 2000 Polytetramethylenglykolpolyol, OH number 56 mg KOH / g, number average molecular weight 2000 g / mol (BASF AG, Ludwigshafen, DE)
  • PolyTHF ® 1000 Polytetramethylenglykolpolyol, OH number 112 mg KOH / g, number-average number average molecular weight 1000 g / mol (BASF AG, Ludwigshafen, DE)
  • Polyether LB 25 monofunctional ethylene oxide / propylene oxide-based polyether number-average molecular weight 2250 g / mol, OH number 25 mg KOH / g (Bayer MaterialScience AG, Leverkusen, DE) Stokal ® STA: Ammonium stearate-based foam additive, active substance content: 30% (Bozzetto GmbH, Krefeld, DE)
  • Stokal ® SR Succinamate-based foaming agent, active substance content: approx. 34% (Bozzetto GmbH, Krefeld, DE)
  • Simulsol ® SL 26 Alkyl polyglycoside based on dodecyl alcohol, approx.
  • the determination of the mean particle sizes (indicated by the number average) of the polyurethane dispersions was carried out by means of laser correlation spectroscopy (instrument: Malvern Catalyst 1000, Malver Inst. Limited).
  • NCO value was reached.
  • the finished prepolymer was dissolved with 4830 g of acetone and thereby cooled to 50 0 C and then a solution of 25.1 g of ethylenediamine, 116.5 g of isophoronediamine, 61.7 g of diaminosulfonate and 1030 g of water was added within 10 min. The stirring time was 10 min. Then was dispersed by adding 1250 g of water. This was followed by removal of the solvent by distillation in vacuo.
  • the resulting white dispersion had the following properties:
  • Viscosity (viscometer, 23 ° C): 241 mPas pH (23 ° C): 6.02
  • the finished prepolymer was dissolved with 1005 g of acetone while cooled to 50 0 C and then a solution of 5.70 ethylenediamine, 26.4 g of isophoronediamine, 9.18 g of diaminosulfonate and 249.2 g of water was added within 10 min. The stirring time was 10 min. It was then dispersed by adding 216 g of water. This was followed by removal of the solvent by distillation in vacuo.
  • the resulting white dispersion had the following properties:
  • Viscosity (viscometer, 23 ° C): 133 mPas pH (23 ° C): 6.92
  • NCO value was reached.
  • the finished prepolymer was dissolved with 4830 g of acetone while cooled to 50 0 C and then a solution of 36.9 g of 1, 4-diaminobutane, 116.5 g of isophoronediamine, 61.7 g of diaminosulfonate and 1076 g of water within 10 min.
  • the stirring time was 10 min. It was then dispersed by adding 1210 g of water. This was followed by removal of the solvent by distillation in vacuo.
  • the resulting white dispersion had the following properties:
  • Viscosity (viscometer, 23 ° C): 126 mPas pH (23 ° C): 7.07
  • the resulting white dispersion had the following properties:
  • Viscosity (viscometer, 23 ° C): 57 mPas pH (23 ° C): 6.64
  • the resulting white dispersion had the following properties:
  • Viscosity (viscometer, 23 ° C): 84 mPas pH (23 ° C): 6.91
  • NCO value was reached.
  • the finished prepolymer was dissolved with 4820 g of acetone and thereby cooled to 50 0 C and then a solution of 27.3 g of ethylenediamine, 126.5 g of isophoronediamine, 67.0 g of diaminosulfonate and 1090 g of water was added within 10 min. The stirring time was 10 min. It was then dispersed by adding 1180 g of water. This was followed by removal of the solvent by distillation in vacuo.
  • the resulting white dispersion had the following properties:
  • Viscosity (viscometer, 23 0 C): 286 mPas pH (23 ° C): 7.15
  • Polyurethane dispersion not according to the invention (no sulfonate groups, but only hydrophilization by non-ionic groups and carboxylate groups)
  • LB 25 polyether were heated in a standard stirring apparatus at 70 0 C. Subsequently, a mixture of 49.7 g of hexamethylene diisocyanate and 65.6 g of isophorone diisocyanate was added at 70 0 C within 5 min and stirred at 120 0 C until the theoretical NCO value was reached.
  • the finished prepolymer was dissolved with 1010 g of acetone while cooled to 50 0 C and then a solution of 5.3 g of ethylenediamine, 24.4 g Isophoronediamine, 11.9 g KV 1386 (40% aqueous solution of the sodium salt of N- (2-aminoethyl) - ⁇ -alanine, BASF AG, Ludwigshafen, DE) and 204 g of water added within 10 min. The stirring time was 10 min. Then it was dispersed by adding 235 g of water. This was followed by removal of the solvent by distillation in vacuo. Due to the high viscosity, a total of 250 g of water had to be added
  • the resulting white dispersion had the following properties:
  • Viscosity (viscometer, 23 ° C): 162 mPas pH (23 ° C): 7.22
  • Polyurethane dispersion not according to the invention (no sulfonate groups, but only hydrophilization by non-ionic groups and carboxylate groups)
  • the finished prepolymer was dissolved with 1010 g of acetone while cooled to 50 0 C and then a solution of 5.3 g of ethylenediamine, 21.8 g of isophoronediamine, 17.9 g KV 1386 (40% aqueous solution of the sodium salt of N - (2-aminoethyl) -ß-alanine, BASF AG, Ludwigshafen, DE) and 204 g of water added within 10 min. The stirring time was 10 min. Then it was dispersed by adding 235 g of water. This was followed by removal of the solvent by distillation in vacuo. The resulting white dispersion had the following properties:
  • Viscosity (viscometer, 23 0 C): 176 mPas pH (23 ° C): 8.31
  • Example 7 In contrast to Example 7, this polyurethane dispersion now shows a smaller average particle size, but a somewhat higher pH. Further processing into wound dressings was significantly more difficult compared to purely sulfonate-hydrolyzed dispersions.
  • Examples 9 to 14 foams prepared from the polyurethane dispersions of Examples 1 to 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Materials Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Manufacturing & Machinery (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
PCT/EP2007/002801 2006-04-08 2007-03-29 Verfahren zur herstellung von polyurethan-schäumen Ceased WO2007115697A1 (de)

Priority Applications (8)

Application Number Priority Date Filing Date Title
EP07723745.1A EP2010235B1 (de) 2006-04-08 2007-03-29 Verfahren zur herstellung von polyurethan-schäumen
MX2008012955A MX2008012955A (es) 2006-04-08 2007-03-29 Metodo para la produccion de espumas de poliuretano.
AU2007236253A AU2007236253A1 (en) 2006-04-08 2007-03-29 Method for production of polyurethane foams
CN2007800212484A CN101466413B (zh) 2006-04-08 2007-03-29 生产聚氨酯泡沫的方法
BRPI0709826-0A BRPI0709826A2 (pt) 2006-04-08 2007-03-29 processo para a produÇço de espumas de poliuretano
JP2009504604A JP2009534478A (ja) 2006-04-08 2007-03-29 ポリウレタンフォームの製造方法
CA002648362A CA2648362A1 (en) 2006-04-08 2007-03-29 Method for production of polyurethane foams
IL194551A IL194551A0 (en) 2006-04-08 2008-10-06 Method for production of polyurethane foams

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006016639A DE102006016639A1 (de) 2006-04-08 2006-04-08 Verfahren zur Herstellung von Polyurethan-Schäumen
DE102006016639.6 2006-04-08

Publications (1)

Publication Number Publication Date
WO2007115697A1 true WO2007115697A1 (de) 2007-10-18

Family

ID=38109482

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/002801 Ceased WO2007115697A1 (de) 2006-04-08 2007-03-29 Verfahren zur herstellung von polyurethan-schäumen

Country Status (14)

Country Link
US (1) US20070254974A1 (enExample)
EP (1) EP2010235B1 (enExample)
JP (1) JP2009534478A (enExample)
KR (1) KR20090026131A (enExample)
CN (1) CN101466413B (enExample)
AU (1) AU2007236253A1 (enExample)
BR (1) BRPI0709826A2 (enExample)
CA (1) CA2648362A1 (enExample)
DE (1) DE102006016639A1 (enExample)
IL (1) IL194551A0 (enExample)
MX (1) MX2008012955A (enExample)
RU (1) RU2008143907A (enExample)
TW (1) TW200808884A (enExample)
WO (1) WO2007115697A1 (enExample)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008031520A1 (de) * 2006-09-16 2008-03-20 Bayer Materialscience Ag Alkylpolyglycoside als stabilisatoren für pur-schäume
WO2009043497A1 (en) * 2007-10-05 2009-04-09 Bayer Innovation Gmbh Production of polyurethane foams
WO2009074192A1 (de) * 2007-12-12 2009-06-18 Bayer Materialscience Ag Energiewandler hergestellt aus filmbildenden wässrigen polymer-dispersionen, insbesondere polyurethan-dispersionen
EP2105125A1 (de) * 2008-03-26 2009-09-30 Bayer MaterialScience AG Hautpflege-Zusammensetzung
EP2105120A1 (de) * 2008-03-26 2009-09-30 Bayer MaterialScience AG Kosmetische Zusammensetzungen zum Auftrag auf die Haut
EP2105126A1 (de) * 2008-03-26 2009-09-30 Bayer MaterialScience AG Dekorative kosmetische Zusammensetzungen
EP2105127A1 (de) * 2008-03-26 2009-09-30 Bayer MaterialScience AG Haarfestiger-Zusammensetzung
EP2182559A1 (de) * 2008-10-30 2010-05-05 Bayer MaterialScience AG Energiewandler auf Basis von Polyurethan-Lösungen
WO2010083952A1 (de) * 2009-01-24 2010-07-29 Bayer Materialscience Ag Polyurethan-tensid-stabilisierte polyurethan-schäume
WO2012130683A1 (de) * 2011-03-25 2012-10-04 Bayer Materialscience Ag Polyurethanharnstoff-mischung für die haarkosmetik
EP2271305B1 (de) * 2008-03-26 2019-09-04 Covestro Deutschland AG Sonnenschutz-zusammensetzungen

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8629195B2 (en) 2006-04-08 2014-01-14 Bayer Materialscience Ag Production of polyurethane foams
EP2045278A1 (de) * 2007-10-05 2009-04-08 Bayer MaterialScience AG Verfahren zur Herstellung von Polyurethan-Schäumen
US20080102157A1 (en) * 2006-10-25 2008-05-01 Steffen Hofacker Flavored chewable foams and a process for their production
EP2028223A1 (de) * 2007-08-23 2009-02-25 Bayer MaterialScience AG EO/PO-Blockcopolymere als Stabilisatoren für PUR-Schäume
CN101827632A (zh) * 2007-10-19 2010-09-08 拜尔材料科学股份公司 用于化妆品的芳香咀嚼泡沫体的制备方法
US20090118387A1 (en) * 2007-11-07 2009-05-07 Inoac Corporation Method for Producing Water-Absorbing Polyurethane Foam
EP2103316A1 (de) * 2008-03-20 2009-09-23 Bayer MaterialScience AG Hydrophile Polyurethandispersionen
US20110027211A1 (en) * 2008-03-26 2011-02-03 Bayer Materialscience Ag Hair styling composition
DE102008025614A1 (de) * 2008-05-28 2009-12-03 Bayer Materialscience Ag Hydrophile Polyurethanbeschichtungen
DE102008025613A1 (de) * 2008-05-28 2009-12-03 Bayer Materialscience Ag Hydrophile Polyurethanbeschichtungen
GB0813040D0 (en) * 2008-07-16 2008-08-20 First Water Ltd Compositions for use as or in wound dressings
US8454990B2 (en) * 2008-08-01 2013-06-04 Milliken & Company Composite article suitable for use as a wound dressing
US8791200B2 (en) 2008-09-04 2014-07-29 Bayer Materialscience Ag TCD based hydrophilic polyurethane dispersions
US8624077B2 (en) 2008-10-02 2014-01-07 L.R.R.&D. Ltd. Interface layer wound dressing
AR074999A1 (es) * 2009-01-24 2011-03-02 Bayer Materialscience Ag Espumas de dispersion de poliuretano de dos componentes
KR101728568B1 (ko) * 2009-06-10 2017-04-19 코베스트로 도이칠란드 아게 폴리(thf)-기재 폴리우레탄 분산액
ES2661365T3 (es) * 2010-03-05 2018-03-28 Covestro Deutschland Ag Composiciones de protección solar
KR102308495B1 (ko) * 2013-12-02 2021-10-06 바스프 에스이 감소된 알데히드 방출을 지닌 폴리우레탄
US20160017084A1 (en) * 2014-06-04 2016-01-21 Pwe, Llc Mechanically Frothed Gel Elastomers and Methods of Making and Using Them
TW201627366A (zh) * 2014-09-17 2016-08-01 3M新設資產公司 親水性開孔發泡體
CN105251240B (zh) * 2015-11-17 2017-06-30 中国科学院兰州化学物理研究所 无溶剂制备新型超疏水聚氨酯油水分离材料的方法
CN106916273B (zh) 2015-12-28 2021-06-15 科思创德国股份有限公司 聚氨酯脲水性分散体
CN111363186B (zh) * 2018-12-25 2023-01-13 万华化学集团股份有限公司 聚氨酯泡沫材料及其制备方法和在伤口敷料中的应用
CN110183609B (zh) * 2019-04-23 2021-12-24 合肥科天水性科技有限责任公司 一种无溶剂聚氨酯树脂及其应用
KR102775536B1 (ko) * 2019-10-28 2025-03-06 디아이씨 가부시끼가이샤 발포 시트, 및, 합성 피혁

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4418319A1 (de) * 1994-05-26 1995-11-30 Stockhausen Chem Fab Gmbh Schichtförmig aufgebauter Körper zur Absorption von Flüssigkeiten sowie seine Herstellung
DE19804665A1 (de) * 1998-02-06 1999-08-12 Beiersdorf Ag Okklusionspflaster
WO2000074739A1 (de) * 1999-06-08 2000-12-14 Beiersdorf Ag Polyurethanträgerfolie mit hydrophobierungsmitteln für filmpflaster
WO2002090413A1 (de) * 2001-05-09 2002-11-14 Bayer Aktiengesellschaft Polyurethan-polyharnstoff dispersionen als beschichtungsmittel
US20040138319A1 (en) * 2003-01-10 2004-07-15 Fomo Products, Inc. Elastomeric latex foams
US20050037058A1 (en) * 2003-08-14 2005-02-17 Canada T. Andrew Method for producing a silver-containing wound care device

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4108814A (en) * 1974-09-28 1978-08-22 Bayer Aktiengesellschaft Aqueous polyurethane dispersions from solvent-free prepolymers using sulfonate diols
US5445604A (en) * 1980-05-22 1995-08-29 Smith & Nephew Associated Companies, Ltd. Wound dressing with conformable elastomeric wound contact layer
US4995382A (en) * 1981-02-13 1991-02-26 Smith And Nephew Associated Companies Limited Wound dressing, manufacture and use
NZ199684A (en) * 1981-02-13 1985-03-20 Smith & Nephew Ass Wound dressing;wound facing layer a conformable elastomeric integral net
US4753231A (en) * 1981-02-13 1988-06-28 Smith & Nephew Associated Companies P.L.C. Adhesive wound dressing
US4860737A (en) * 1981-02-13 1989-08-29 Smith And Nephew Associated Companies P.L.C. Wound dressing, manufacture and use
DE3231062A1 (de) * 1982-08-20 1984-02-23 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von beschichtungsmassen, waessrige dispersionen von pu-reaktiv-systemen und ihre verwendung zur beschichtung
US5252657A (en) * 1984-12-20 1993-10-12 Rohm And Haas Company Modified latex polymer composition
GB8524579D0 (en) * 1985-10-04 1985-11-06 Polyvinyl Chemicals Inc Coating compositions
JP2710306B2 (ja) * 1985-10-31 1998-02-10 東レ株式会社 高透湿性防水布帛およびその製造方法
US4655210A (en) * 1986-01-17 1987-04-07 Seton Company Foam bandage
US4675232A (en) * 1986-05-19 1987-06-23 Seton Company Self-release foam laminate
GB9102660D0 (en) * 1991-02-07 1991-03-27 Ultra Lab Ltd Wound dressing materials
US5110843A (en) * 1991-05-01 1992-05-05 Minnesota Mining And Manufacturing Company Absorbent, non-skinned foam and the method of preparation
US5266323A (en) * 1991-05-24 1993-11-30 Hampshire Chemical Corp. Degradable articles and methods of using such articles as degradable bait
AU7917298A (en) * 1997-07-09 1999-02-08 Huntsman Ici Chemicals Llc Compressed hydrophilic polyurethane foams
DE19836476A1 (de) * 1998-08-12 2000-02-17 Basf Ag Hydrophile Polyurethan-Weichschaumstoffe
US5997969A (en) * 1998-08-27 1999-12-07 Gardon; John L. Non-allergenic medical and health care devices made from crosslinked synthetic elastomers
AU760247B2 (en) * 1998-12-29 2003-05-08 Dow Global Technologies Inc. Polyurethane foams prepared from mechanically frothed polyurethane dispersions
DE19930526A1 (de) * 1999-07-01 2001-01-04 Basf Ag Hydrophile Polyurethan-Weichschaumstoffe
KR100550807B1 (ko) * 2002-10-29 2006-02-09 주식회사 바이오폴 충전형 폴리우레탄 폼 드레싱재 및 그 제조방법
US20040116594A1 (en) * 2002-12-11 2004-06-17 Debkumar Bhattacharjee Polyurethane prepolymer, stable aqueous dispersions with high solids containing the same and method of using and preparing the aqueous dispersions
WO2004103415A2 (en) * 2003-05-20 2004-12-02 Avery Dennison Corporation Multi-dressing system for managing skin wounds

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4418319A1 (de) * 1994-05-26 1995-11-30 Stockhausen Chem Fab Gmbh Schichtförmig aufgebauter Körper zur Absorption von Flüssigkeiten sowie seine Herstellung
EP0760743A1 (de) 1994-05-26 1997-03-12 STOCKHAUSEN GmbH & CO. KG Schichtförmig aufgebauter körper zur absorption von flüssigkeiten
DE19804665A1 (de) * 1998-02-06 1999-08-12 Beiersdorf Ag Okklusionspflaster
WO2000074739A1 (de) * 1999-06-08 2000-12-14 Beiersdorf Ag Polyurethanträgerfolie mit hydrophobierungsmitteln für filmpflaster
WO2002090413A1 (de) * 2001-05-09 2002-11-14 Bayer Aktiengesellschaft Polyurethan-polyharnstoff dispersionen als beschichtungsmittel
US20040138319A1 (en) * 2003-01-10 2004-07-15 Fomo Products, Inc. Elastomeric latex foams
US20050037058A1 (en) * 2003-08-14 2005-02-17 Canada T. Andrew Method for producing a silver-containing wound care device

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008031520A1 (de) * 2006-09-16 2008-03-20 Bayer Materialscience Ag Alkylpolyglycoside als stabilisatoren für pur-schäume
WO2009043497A1 (en) * 2007-10-05 2009-04-09 Bayer Innovation Gmbh Production of polyurethane foams
WO2009074192A1 (de) * 2007-12-12 2009-06-18 Bayer Materialscience Ag Energiewandler hergestellt aus filmbildenden wässrigen polymer-dispersionen, insbesondere polyurethan-dispersionen
WO2009118106A1 (de) * 2008-03-26 2009-10-01 Bayer Materialscience Ag Dekorative kosmetische zusammensetzungen
WO2009118107A3 (de) * 2008-03-26 2009-12-03 Bayer Materialscience Ag Hautpflege-zusammensetzung
EP2105126A1 (de) * 2008-03-26 2009-09-30 Bayer MaterialScience AG Dekorative kosmetische Zusammensetzungen
EP2105127A1 (de) * 2008-03-26 2009-09-30 Bayer MaterialScience AG Haarfestiger-Zusammensetzung
WO2009118104A1 (de) * 2008-03-26 2009-10-01 Bayer Materialscience Ag Kosmetische zusammensetzungen zum auftrag auf die haut
EP2105125A1 (de) * 2008-03-26 2009-09-30 Bayer MaterialScience AG Hautpflege-Zusammensetzung
WO2009118105A1 (de) * 2008-03-26 2009-10-01 Bayer Materialscience Ag Haarfestiger-zusammensetzung
EP2105120A1 (de) * 2008-03-26 2009-09-30 Bayer MaterialScience AG Kosmetische Zusammensetzungen zum Auftrag auf die Haut
EP2271305B1 (de) * 2008-03-26 2019-09-04 Covestro Deutschland AG Sonnenschutz-zusammensetzungen
US10045930B2 (en) 2008-03-26 2018-08-14 Covestro Deutschland Ag Decorative cosmetic compositions
CN102197503A (zh) * 2008-10-30 2011-09-21 拜尔材料科学股份公司 以聚氨酯溶液为基础的能量转换器
WO2010049079A1 (de) * 2008-10-30 2010-05-06 Bayer Materialscience Ag Energiewandler auf basis von polyurethan-lösungen
EP2182559A1 (de) * 2008-10-30 2010-05-05 Bayer MaterialScience AG Energiewandler auf Basis von Polyurethan-Lösungen
WO2010083952A1 (de) * 2009-01-24 2010-07-29 Bayer Materialscience Ag Polyurethan-tensid-stabilisierte polyurethan-schäume
WO2012130683A1 (de) * 2011-03-25 2012-10-04 Bayer Materialscience Ag Polyurethanharnstoff-mischung für die haarkosmetik

Also Published As

Publication number Publication date
MX2008012955A (es) 2008-10-17
AU2007236253A1 (en) 2007-10-18
CN101466413A (zh) 2009-06-24
EP2010235A1 (de) 2009-01-07
CA2648362A1 (en) 2007-10-18
US20070254974A1 (en) 2007-11-01
EP2010235B1 (de) 2014-01-15
BRPI0709826A2 (pt) 2011-07-26
DE102006016639A1 (de) 2007-10-11
CN101466413B (zh) 2013-03-13
KR20090026131A (ko) 2009-03-11
JP2009534478A (ja) 2009-09-24
RU2008143907A (ru) 2010-05-20
TW200808884A (en) 2008-02-16
IL194551A0 (en) 2009-08-03

Similar Documents

Publication Publication Date Title
EP2010235B1 (de) Verfahren zur herstellung von polyurethan-schäumen
EP2197930B1 (de) Verfahren zur herstellung von polyurethan-schäumen
EP2007444B1 (de) Polyurethan-schäume für die wundbehandlung
EP2183309B1 (de) Eo/po-blockcopolymere als stabilisatoren für pur-schäume
DE102007048079A1 (de) Verfahren zur Herstellung von Polyurethan-Schäumen
EP2066711B1 (de) Alkylpolyglycoside als stabilisatoren für pur-schäume
EP2045279A1 (de) Polyurethan-Schäume für die Wundbehandlung
EP2181133B1 (de) Mikroporöse beschichtung auf basis von polyurethan-polyharnstoff
EP2389400B1 (de) Verwendung zweikomponentiger polyurethan-dispersionsschäume als wundauflagen
EP2389402B1 (de) Polyurethan-Tensid-stabilisierte Polyurethan-Schäume
DE102007048078A1 (de) Polyurethan-Schäume für die Wundbehandlung
DE102007048080A1 (de) Biomedizinische Schaumartikel
EP2159255A1 (de) Verfahren zur Herstellung von geformten Polyurethanschaum-Wundauflagen
EP2318056B1 (de) Verfahren zur herstellung von geformten polyurethanschaum-wundauflagen
WO2012032032A1 (de) Verfahren zur herstellung hydrophiler polyurethanschäume
HK1134259A (en) Method for production of polyurethane foams

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780021248.4

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07723745

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2007723745

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2648362

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 194551

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: MX/a/2008/012955

Country of ref document: MX

Ref document number: 8419/DELNP/2008

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2009504604

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007236253

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1020087027370

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2008143907

Country of ref document: RU

ENP Entry into the national phase

Ref document number: 2007236253

Country of ref document: AU

Date of ref document: 20070329

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: PI0709826

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20081008